Wikidata

(Q113887943)

English

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoC-2 Virus Infection (COVID-19). A Pilot, Randomized, Simple Blind, Placebo-controlled, Parallel-group Study (English)
0 references
medical condition
COVID-19
0 references
pneumonia
0 references
country
Argentina
0 references
start time
26 June 2020
0 references
end time
15 November 2020
0 references
number of participants
135
0 references
minimum age
18 year
0 references
maximum age
59 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113887943&oldid=2149446866"